TheProfitWatch

TVTX - Travere Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
34.12 1.15 (3.37%) 0.01 (0.03%) -0.08 (-0.23%) 0.05 (0.16%) 0.61 (1.79%) 0.57 (1.64%) 0.0 (0.0%) 0.0 (0.0%)

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.14
Diluted EPS:
-0.14
Basic P/E:
-251.9286
Diluted P/E:
-251.9286
RSI(14) 1m:
59.44
VWAP:
35.24
RVol:

Events

Period Kind Movement Occurred At

Related News